NASDAQ: INTS
Intensity Therapeutics Inc Stock Ownership - Who owns Intensity Therapeutics?

Insider buying vs selling

Have Intensity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John M. WesolowskiPrincipal Accounting Officer2024-06-051,000$4.00
$4.00kBuy

1 of 1

INTS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INTS insiders and whales buy or sell their stock.

INTS Shareholders

What type of owners hold Intensity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lewis H. Bender13.17%2,000,000$1.08MInsider
Armistice Capital LLC7.42%1,126,868$606.25kInstitution
Sapient Capital LLC6.21%942,841$507.25kInstitution
Vanguard Group Inc1.38%208,886$112.38kInstitution
Brown Advisory Inc0.86%130,072$69.98kInstitution
Geode Capital Management LLC0.42%64,349$34.62kInstitution
Sigma Planning Corp0.36%54,837$29.50kInstitution
Blair William Co0.25%37,805$20.34kInstitution
One Charles Private Wealth Services LLC0.21%31,800$17.11kInstitution
Blackrock Inc0.15%22,252$11.97kInstitution

1 of 3

INTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INTS17.92%13.22%Net Buying
TSBX44.05%55.95%
BCLI1.19%98.81%Net Buying
CARM11.70%73.98%
EVGN6.17%0.00%

Intensity Therapeutics Stock Ownership FAQ

Who owns Intensity Therapeutics?

Intensity Therapeutics (NASDAQ: INTS) is owned by 17.92% institutional shareholders, 13.22% Intensity Therapeutics insiders, and 68.86% retail investors. Lewis H. Bender is the largest individual Intensity Therapeutics shareholder, owning 2.00M shares representing 13.17% of the company. Lewis H. Bender's Intensity Therapeutics shares are currently valued at $1.03M.

If you're new to stock investing, here's how to buy Intensity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.